Detail akcie Atrion Corp online

Business Summary: Atrion Corporation develops and manufactures products, primarily for medical applications. The Company's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. It has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The Company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Atrion Corp revenues decreased 8% to $169.3M. Net income decreased 45% to $19.4M. Revenues reflect Fluid Delivery segment decrease of 15% to $71.1M, Other segment decrease of 24% to $19.8M, All other Regions segment decrease of 13% to $37.8M, European Union segment decrease of 17% to $25.1M. Net income also reflects Selling/General/Admin. Expense increase of 13% to $21.7M (expense).